AGIO

27.6004.03%
KV

Krishnan Viswanadhan

Chief Strategy & Operations Officer

Dr. Krishnan Viswanadhan, M.B.A. & Pharm.D. had been Independent Non-Executive Director of JW (Cayman) Therapeutics Co. Ltd since August 29, 2023 until July 31, 2024 and served as its Non-Executive Director of JW (Cayman) Therapeutics Co. Ltd from November 20, 2019 until August 29, 2023. He serves as Chief Strategy and Operations Officer at Agios Pharmaceuticals, Inc. from May 2026 and served as its Chief Corporate Development and Strategy Officer from March 2025 to May 2026. He served as President & Chief Operating Officer of Be Biopharma, Inc. since August 2021 until March 2025. He served as Independent Director at CARGO Therapeutics, Inc. since October 2022 until August 18, 2025. Prior to joining Be Bio, Dr. Viswanadhan served as Senior Vice President of Global Cell Therapy Franchise Lead at Bristol Myers-Squibb (BMS). In this role, he was responsible for setting the vision and developing the integrated, enterprise-wide cell therapy franchise strategy, building core capabilities and driving key investments to support long-term growth. He oversaw the program team leaders responsible for the cross-functional development, registration and lifecycle management of Breyanzi® (liso-cel), a CD19 CAR T in large B cell lymphoma and Abecma® (ide-cel), the first BCMA CAR T in relapsed/refractory multiple myeloma. Dr. Viswanadhan joined the JW (Cayman) Therapeutics Co. Ltd on November 20, 2019. He is primarily responsible for supervising and providing oversight to the Board. Dr. Viswanadhan has been Acting as a Senior Vice President and global cell therapy franchise lead at BMS since August 2019. Prior to that, he served as Vice President of Business Development and Global Alliances at Celgene. Prior to that role, he was as an Executive Director, global project leader and development leader in 2014. Prior to that, he served at F. Hoffmann-La Roche Ltd. (“Roche”) where he first began as program Manager in the drug regulatory department in July 2002. In July 2001, Dr. Viswanadhan was appointed as a post-doctoral fellow at Rutgers University for a two-year program in industrial clinical pharmacy. Dr. Viswanadhan obtained a Bachelor of Science degree and a Doctor of Pharmacy degree from Rutgers University in the United States in May 2001. He obtained a Master of Business Administration degree from Cornell University in the United States in May 2010.

Positions